Bioventus
BVS
BVS
80 hedge funds and large institutions have $176M invested in Bioventus in 2023 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 25 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
19% more funds holding
Funds holding: 67 → 80 (+13)
0.62% more ownership
Funds ownership: 52.55% → 53.18% (+0.62%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
80
Holding in Top 10
3
Calls
$1.03M
Puts
$421K
Top Buyers
| 1 | +$1.98M | |
| 2 | +$817K | |
| 3 | +$656K | |
| 4 |
LCM
Laurion Capital Management
New York
|
+$623K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$458K |
Top Sellers
| 1 | -$2.65M | |
| 2 | -$929K | |
| 3 | -$552K | |
| 4 |
Bank of New York Mellon
New York
|
-$407K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$392K |